Neil Entwistle
- Efficacy, safety and effect on biomarkers of AZD9668 in cystic fibrosisBy J. Stuart Elborn, John Perrett, Kristina Forsman-Semb, Joanna Marks-Konczalik, Kulasiri Gunawardena and Neil EntwistleJ. Stuart Elborn*Respiratory Medicine Group, Centre for Infection and Immunity, Queen's University, BelfastJohn Perrett#Soluble Biomarkers – Science and Validation, AstraZeneca, Loughborough, UKKristina Forsman-Semb¶Bioscience Dept, AstraZeneca, Lund, SwedenJoanna Marks-Konczalik#Soluble Biomarkers – Science and Validation, AstraZeneca, Loughborough, UKKulasiri Gunawardena#Soluble Biomarkers – Science and Validation, AstraZeneca, Loughborough, UKNeil Entwistle#Soluble Biomarkers – Science and Validation, AstraZeneca, Loughborough, UK
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.